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Ileitis-prone SAMP1/YitFc mice display concomitant
immune-mediated liver inﬂammation, which is driven by
hyperactivated intrahepatic TH1 CD4
þ T effector cells.
Locally impaired hepatic immunosuppression rather than
recruitment of gut-derived cells is likely responsible for the
heightened activation status of these cells.
BACKGROUND & AIMS: Liver inﬂammation is a common
extraintestinal manifestation of inﬂammatory bowel disease
(IBD), but whether liver involvement is a consequence of a
primary intestinal defect or results from alternative pathogenic
processes remains unclear. Therefore, we sought to determine
the potential pathogenic mechanism(s) of concomitant liver
inﬂammation in an established murine model of IBD.
METHODS: Liver inﬂammation and immune cell subsets were
characterized in ileitis-prone SAMP1/YitFc (SAMP) and AKR/J
(AKR) control mice, lymphocyte-depleted SAMP (SAMPxRag-
1/), and immunodeﬁcient SCID recipient mice receiving
SAMP or AKR donor CD4þ T cells. Proliferation and suppressive
capacity of CD4þ T-effector (Teff) and T-regulatory (Treg) cells
from gut-associated lymphoid tissue (GALT) and livers of SAMP
and AKR mice were measured.
RESULTS: Surprisingly, prominent inﬂammation was detected
in 4-week-old SAMP livers before histologic evidence of ileitis,
whereas both disease phenotypes were absent in age-
matched AKR mice. SAMP liver disease was characterized by
abundant inﬁltration of lymphocytes, required for hepatic
inﬂammation to occur, a TH1-skewed environment, and
phenotypically activated CD4þ T cells. SAMP intrahepatic
CD4þ T cells also had the ability to induce liver and ileal
inﬂammation when adoptively transferred into SCID re-
cipients, whereas GALT-derived CD4þ T cells produced milder
ileitis but not liver inﬂammation. Interestingly, SAMP intra-
hepatic CD4þ Teff cells showed increased proliferation
compared with both SAMP GALT- and AKR liver-derived CD4þ
Teff cells, and SAMP intrahepatic Tregs were decreased
among CD4þ T cells and impaired in in vitro suppressive
function compared with AKR.CONCLUSIONS: Activated intrahepatic CD4þ T cells induce
liver inﬂammation and contribute to experimental ileitis via
locally impaired hepatic immunosuppressive function. (Cell Mol
Gastroenterol Hepatol 2015;1:406–419; http://dx.doi.org/
10.1016/j.jcmgh.2015.05.007)
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SAMP1/YitFc Mice.iver disease constitutes one of the most frequentlyLoccurring extraintestinal manifestations of IBD, with
primary sclerosing cholangitis (PSC) representing the most
common hepatobiliary-associated ailment. Besides PSC, a wide
range of liver pathologies have been reported in IBD patients,
including PSC/autoimmune hepatitis (AIH) “overlap syn-
drome,” IgG4-associated cholangitis, primary biliary cirrhosis,
fatty liver, granulomatous hepatitis, cholelithiasis, and portal
vein thrombosis.1 Despite its prevalence, the precise etiology
of liver inﬂammation during IBD is currently unknown.
To date, the most widely accepted hypothesis of IBD-
associated liver disease, particularly PSC, is that it occurs
as a consequence of aberrant adhesion molecule expression
that promotes the recruitment of memory T cells, originally
activated in the gut, to the liver where they drive hepatic
July 2015 Liver Inﬂammation in Ileitis-Prone SAMP Mice 407inﬂammation.2 Speciﬁcally, expression of mucosal addressin
cell adhesion molecule-1 (MAdCAM-1) and CC chemokine
ligand 25 (CCL25), normally restricted to the intestinal
endothelium and small bowel epithelium, respectively, and
which comprise the conventional gut “postal code,”3 have
been implicated as key mediators in this process. In PSC, for
example, MAdCAM-1 and CCL25 are aberrantly expressed
by the portal and sinusoidal endothelium and suggest the
importance of these homing molecules for the migration of
T cells to the liver.4,5 Together, these observations support
the existence of an enterohepatic lymphocyte circulation
that facilitates trafﬁcking of T lymphocytes from the gut to
the liver that can then promote liver inﬂammation.
Alternatively, emerging evidence suggests that
T-lymphocyte priming can also occur locally in the liver
during both homeostatic and pathologic conditions.6–8
Liver-resident antigen-presenting cells (APC), such as liver
sinusoidal endothelial cells (LSEC), dendritic cells (DC), and
Kupffer cells (KC), are capable of interacting with naïve T
cells and have the ability to induce regulatory T cell (Treg)
differentiation and function,9,10 thereby promoting hepatic
immune tolerance.
Of the many available models of IBD, only few allow
investigation of the earliest events associated with the onset
and natural course of disease. SAMP1/YitFc (SAMP) mice
represent a well-characterized model of spontaneous,
chronic intestinal inﬂammation, whose primary disease
location (ie, the terminal ileum), histologic features, and
response to standard therapies closely resemble Crohn’s
disease, one of the idiopathic forms of IBD.11,12 The SAMP
strain was derived from several generations of brother-
sister mating of parental AKR mice with ileitis but not co-
litis developing spontaneously without chemical, genetic, or
immunologic manipulation.11–13 Our initial ﬁndings of liver
disease noted lymphocytic inﬁltration of hepatic portal
tracts in 20- to 30-week-old SAMP mice,13 previously re-
ported by others;14 however, this observation was never
further characterized by either group. Accordingly, SAMP
mice represent an ideal model to evaluate the onset and
progression of liver inﬂammation in the presence of chronic
ileitis and to investigate the relationship and potential
mechanism(s) linking gut and liver pathologies.
Herein, we report both portal and lobular liver inﬂam-
mation that occurs before the onset of gut inﬂammation in
SAMP mice, an established mouse model of Crohn’s disease-
like ileitis. Further characterization of intrahepatic immune
cells conﬁrmed speciﬁc expansion of type 1 helper T (TH1)-
polarized CD4þ T cells that drive severe liver as well as ileal
inﬂammation when adoptively transferred into naïve SCID
recipients. Importantly, intrahepatic CD4þ T cells do not
display a gut-tropic phenotype, suggesting that local over-
activation rather than recruitment of gut-activated CD4þ T
cells may be responsible for the liver disease in SAMP. Indeed,
impaired in vitro suppressive function of hepatic Tregs was
observed in SAMP mice. Taken together, our results challenge
the current paradigm that IBD-associated liver disease rep-
resents a secondary event to gut inﬂammation and raise the
possibility that liver inﬂammation during IBD may develop as
a consequence of impaired immune tolerance within the hostliver, which may also inﬂuence the course of chronic intesti-
nal inﬂammation in individuals predisposed to IBD.
Materials and Methods
Mice
Original AKR/J (AKR), B6.129S7-Rag1tm1Mom/J (Rag-1/),
and C3Smn.CB17-Prkdcscid/J (SCID) mice were purchased
from the Jackson Laboratory (Bar Harbor, ME). SAMP foun-
ders were originally provided by S. Matsumoto (Yakult Cen-
tral Institute for Microbiological Research, Tokyo, Japan).11,13
The SAMPXRag-1/ strain was generated by backcrossing
Rag-1/ mice onto the SAMP background for 10 generations.
All experimental mice were subsequently bred (>20 genera-
tions) and maintained under speciﬁc pathogen-free condi-
tions, fed standard laboratory chow (Harlan Teklad,
Indianapolis, IN), and kept on 12-hour light/dark cycles. All
procedures followed Association for Assessment and
Accreditation of Laboratory Animal Care guidelines and were
approved by Case Western Reserve University’s institutional
animal care and use committee.
Liver Enzyme Levels
Sera from experimental mice were assayed 1:5 for
alkaline phosphatase (ALP) (BioVision, Mountain View, CA),
and undiluted for alanine aminotransferase (ALT) (Genzyme
Diagnostics P.E.I., Charlottetown, PE, Canada) according to
manufacturer’s instructions.
Histology and Immunohistochemistry
Liver and ileal tissues were processed for histo-
logy11,14–20 and evaluated by trained pathologists (T. Ros-
kams, J. Mize) using a novel liver (Table 1) and an
established ileal14,16–22 scoring system. Immunolocalization
of T cells was performed using aCD3 (ab5690/1:50) primary
antibodies (Abcam, Cambridge, MA), and visualized using the
Dako EnVision System (Dako, Carpinteria, CA). Images were
obtained on an Axiophot microscope and assembled by
Axiovision Release 4.5 (Carl Zeiss, Thornwood, NY).
Nonparenchymal Liver Cell Isolation
Nonparenchymal liver cells (NPLCs) were isolated by
perfusing mice with Hank’s balanced salt solution through
the hepatic portal vein, after which livers were removed and
homogenized. Homogenates were incubated with agitation
at 37C for 30 minutes in a solution of collagenase type IV
and DNase I in Hank’s balanced salt solution (Sigma-Aldrich,
St. Louis, MO). Resulting cell suspensions were centrifuged
at 300 rpm at 4C, passed through mm nylon ﬁlters, and
centrifuged again at 1200 rpm at 4C for 10 minutes. ACK
Lysing Buffer (Invitrogen, Carlsbad, CA) was added to cell
pellets for 5 minutes at room temperature and similarly
centrifuged. Cells were washed twice and used
for immediate experimentation, or either further puriﬁed
by centrifugation at 2500 rpm for 30 minutes through a
40%/70% Percoll gradient (Sigma-Aldrich) or enriched for
CD4þ T cells (described herein), after which the cells were
washed twice and then used for experiments.
Table 1.Histologic Scoring System for Liver Disease in SAMP Mice
Area Index Grade Description
Portal area Portal 0 Normal
1 Moderate portal tract expansion with lymphocytic inﬁltration
2 As in 1, plus focal lymphocyte inﬁltration of the limiting plate
3 Severe portal tract expansion with lymphocytic inﬁltration
4 As in 3, plus piecemeal necrosis and periportal lymphocytic
inﬁltration of the liver lobules
Biliary 0 Normal
1 Moderate lymphocytic inﬁltration around biliary ducts
2 As in 1, plus focal lymphocyte inﬁltration of biliary epithelium
3 Severe lymphocyte inﬁltration around biliary ducts
4 Extensive biliary involvement with severe lymphocyte inﬁltration
Lobular area Lobular 0 Normal
1 Few lymphocytes scattered or clustered within lobular area
2 Occasional granulomas
3 Granulomas present in several lobular areas
4 Large and/or conﬂuent granulomas in all lobular areas
Steatosis 0 Normal
1 Moderate steatosis limited to controlobular area
2 Moderate steatosis in all lobular areas
3 Severe steatosis primarily in centrolobular area
4 Massive, diffuse steatosis affecting all lobular areas
Note: Total liver inﬂammatory index is calculated by the sum of portal, biliary, lobular, and steatosis indices multiplied by the
percentage of involvement, assigned as 1 ¼ 0–25%, 2 ¼ 26%–50%, 3 ¼ 51%–75%, and 4 ¼ 76%–100%.
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Single-cell suspensions were prepared from mesenteric
lymph nodes (MLN)18 and livers, and 106 cells stained with
the following antibodies: ﬂuorescein isothiocyanate-labeled
CD8a (53–6.7), PerCP-labeled CD4 (RM4–5), APC-labeled
CD25 (PC61), PE-labeled CD44 (IM7), (BD Pharmingen,
San Diego, CA), APC-labeled a4b7 (PS/2) (AbD Serotec,
United Kingdom), PE-labeled CCR9 (242503) (R&D System,
Minneapolis, MN), APC-labeled CD146 (ME-9F1), APC-Cy7
CD11c (N418), PE-labeled I-Ak (10–3.6), CD69 (H1.2F3),
PE-Cy5 CD3 (145–2C11), ﬂuorescein isothiocyanate-CD19
(6D5) (Biolegend, San Diego, CA), and eFluor 450-labeled
F4/80 (BM8) (eBioscience, San Diego, CA). For intracel-
lular staining, cells were ﬁxed after cell-surface staining,
followed by permeabilization and staining with PE-labeled
forkhead box protein 3 (FoxP3) (FJK-16s) as per the man-
ufacturer’s instructions (eBioscience). Samples were
analyzed with a FACSCalibur or LSR II and CellQuest Soft-
ware (Becton Dickinson, San Jose, CA).Adoptive Transfer Model
Livers and MLNs were harvested from 10- to 12-week-
old donors, rendered into single-cell suspensions, and pu-
riﬁed for CD4þ lymphocytes using magnetic bead separation
(Miltenyi Biotec, Auburn, CA). CD4þ T cells (400,000) were
transferred intraperitoneally into 6- to 8-week-old major
histocompatibility complex (MHC)-matched SCIDs;
untransferred SCIDs receiving phosphate-buffered saline
(vehicle) served as controls. Six weeks after transfer, the
recipient mice were euthanized, and the livers and ilea were
processed for histologic evaluation and intrahepatic CD4þ
T-cell isolation, again using magnetic bead separation (Mil-
tenyi Biotec).Cytokine mRNA Expression
The NPLC and ex vivo-cultured aCD3/CD28-activated
CD4þ T cells22 were lysed in Buffer RLT (Qiagen, Ger-
mantown, MD) immediately after collection. The total
RNA was isolated using RNeasy Mini Kits (Qiagen) and
reverse-transcribed to cDNA (RNA-to-cDNA kit; Applied
Biosystems, Forest City, CA). Real-time quantitative poly-
merase chain reaction was performed using primers for
TH1 and TH2 cytokines,
15 IL-33,22 IL-1a (50-TTTCCA
CAGCCACGAAGCT-30; 50-TGATGAAAGGGCTCCCAAGTA-30),
IL-1b (50-TCCTTAGTCCTCGGCCAAGAC-30; 50-GTGCCAT
GGTTTCTTGTGACC-30), and IL-18 (50-CACTGTACAACCG
CAGTAATACGG-30; 50-CAGCCAGTCCTCTTACTTCACTGT-30),
with target gene expression normalized to b-actin.
In Vitro T cell Functional Assays
The CD4þCD25 effector T cells (Teff) and CD4þCD25þ
(Treg) cells were isolated by ﬂuorescence-activated cell
sorting (FACS) from liver or MLN of SAMP and AKR mice.
Teff cells were labeled with eFluor 670 (5-(6)-carboxy-
ﬂuorescein diacetate succinimidyl ester analog, 0.5 mM) and
cultured either with or without a 1:1 ratio of Tregs. aCD3
(1 mg/mL), and aCD28 (1 mg/mL) coated beads (Miltenyi
Biotec) were added to cultures at a 1:0.8 Teff:bead ratio.
Proliferation was determined after 3 days of culture by ﬂow
cytometric dye dilution assays.
MAdCAM-1 and CCL25 Protein Levels
Livers were collected and homogenized in radio-
immunoprecipitation assay buffer supplemented with Halt
proteases and phosphate inhibitor cocktail (Pierce
Biotechnology, Rockford, IL), using lysing matrix tubes and
FastPrep-24 (MP Biomedicals, Santa Ana, CA). Homogenates
Figure 1. Liver inﬂammation in young, ileitis-prone
SAMP1/YitFc (SAMP). (A) Serum liver enzyme levels in
4-week-old mice (n ¼ 12). Representative histologic photo-
micrographs of (B, D) inﬂamed neonatal (1-week-old) SAMP
liver with enlarged portal tracts ﬁlled with dense inﬂammatory
inﬁltrates surrounding bile ducts versus (C, E) age-matched
AKR/J (AKR) with normal, noninﬂamed morphology. PV,
portal vein. Bars: (B, C) 100 mm, (D, E) 20 mm; ***P < .001.
July 2015 Liver Inﬂammation in Ileitis-Prone SAMP Mice 409were centrifuged at 12,000 rpm, the supernatants collected,
and the total protein content measured using BCA Protein
Assay kits (Pierce Biotechnology). After normalizing the
protein content, we assayed the tissue homogenates for
MAdCAM-1 and CCL25 protein by ELISA (R&D Systems).
Statistical Analysis
Two-tailed unpaired Student t test was performed using
GraphPad Prism 5 (GraphPad Software, La Jolla, CA). The
results are expressed as mean ± standard error of the mean
(SEM); P < .05 was considered statistically signiﬁcant. All
authors had access to the study data and reviewed and
approved the ﬁnal manuscript.
Results
SAMP Mice Display Liver Inﬂammation Before
the Onset of Ileitis
The onset of liver disease in SAMP mice was investigated
because previous reports had described liver inﬂammation
in 20- to 30-week-old adults13,14 yet it was unknown
whether younger mice also exhibited liver inﬂammation and
when this phenotype initially emerged. Our results showed
that elevated circulating levels of ALP and ALT were
detected in 4-week-old SAMP mice compared with age-
matched AKR mice (Figure 1A) when no histologic evi-
dence of ileitis is generally present,11–13 indicating that liver
disease can precede ileitis. This was conﬁrmed by histologic
evaluation of SAMP livers that revealed diffuse inﬂamma-
tory inﬁltrates involving both portal and lobular areas,
even during the early stages of postnatal development at 1
week of age (see Figure 1B and D), which were absent in
AKR livers (see Figure 1C and E). Conversely, adjacent in-
testinal tissues in both SAMP and AKR mice displayed
completely normal morphology at this early age (see
Figure 1B and C).
A detailed time-course study was then performed to
further characterize the development of liver disease and
coprogression with ileal inﬂammation. Histologic evaluation
was done using a novel scoring system (see Table 1) on
livers from SAMP and age/sex-matched AKR mice, based on
critical time points in the development of SAMP ileitis, as
follows: 3–4 weeks (before histologic evidence of ileitis, but
presence of small intestinal epithelial permeability defect),
7–9 weeks (early, active phase of inﬂammation and domi-
nant TH1 cytokine proﬁle), and >12 weeks (established,
chronic inﬂammation and mixed TH1/TH2 cytokine proﬁle);
after 20 weeks, no signiﬁcant differences are observed in
the severity of ileitis among SAMP mice.12
A key observation in the present study was that peak
liver inﬂammation occurred at 4 weeks in SAMP mice, when
ileitis is normally absent (Figure 2A). Ileitis began to pro-
gressively increase in severity, reaching maximum inﬂam-
mation by 20 weeks whereas liver inﬂammation gradually
diminished, most signiﬁcantly in areas of lobular compared
with portal involvement (see Figure 2A). Consistent with
these ﬁndings, at 20 weeks of age the circulating levels of
ALP and ALT in SAMP mice were comparable to the AKR
controls (Figure 3), indicative of the progressive decrease inthe severity of liver inﬂammation. With regard to pene-
trance, the incidence of SAMP mice developing severe liver
disease gradually decreased until 40 weeks (see Figure 2B);
unlike in SAMP ileitis,23 no sex differences were observed in
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Figure 3. Circulating levels of alkaline phosphatase (ALP)
and alanine aminotransferase (ALT) are comparable in
SAMP1/YitFc (SAMP) versus AKR/J (AKR) mice at 20
weeks of age. Serum liver enzyme levels in 20-week-old
mice as measured by enzyme-linked immunosorbent assay
(n ¼ 12). n.s., not statistically signiﬁcant.Figure 2. Liver inﬂammation in SAMP1/YitFc (SAMP) pre-cedes ileitis and decreases over time. (A) Time-course of
SAMP liver and ileal inﬂammation (n ¼ 24). (B) Incidence and
severity of liver disease (n ¼ 24). TIS ¼ total inﬂammatory
score. ***P < .001, ‡P < .01 versus 4-week-olds.
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shown).
The main histopathologic features in SAMP livers
consisted of portal tract inﬂammation characterized by lym-
phocytic inﬁltrates, eosinophilic polymorphonuclear cells,
macrophages, as well as focal hepatitis with lymphocytes
inﬁltrating the portal-parenchymal interface (Figure 4A) with
inﬂammatory bridging between portal tracts (see Figure 4B).
In addition to prominent portal tract involvement, other
pathologic features recapitulated most of those described in
IBD,1 such as hepatocyte anisokaryosis, granuloma-like or-
ganization of lobular inﬂammatory inﬁltrates, and sinusoidal
inﬂammation with mild microvesicular steatosis (see
Figure 4D–F). Remarkably, the bile duct epithelium displayed
evident ductular proliferation (see Figure 4C) and was focally
inﬁltrated by CD3þ T lymphocytes (see Figure 4G). Overall,
the general histopathologic ﬁndings were indicative of
immune-mediated liver disease involving both portal tracts
and liver lobules with inﬁltration of biliary ducts, reminiscent
of the clinical phenotype of PSC/AIH overlap syndrome.
Lymphocytes Are Required to Induce Liver
Inﬂammation in SAMP and Consist
Predominantly of Activated CD4þ T Cells
We further characterized the immune cell inﬁltrates in
young SAMP liver during the peak of inﬂammation by ﬂow
cytometry accordingly to the gating strategy illustrated in
Figure 5. A marked increase in CD3þ T-lymphocytes previ-
ously highlighted by immunohistochemistry (see Figure 4G)
was conﬁrmed in SAMP compared with AKR livers (Figure 6A
and B). Surprisingly, the frequencies of hepatic F4/80þ mac-
rophages, CD11cþ DCs, and CD19þ B-lymphocytes, comparing
the SAMP and AKR mice, were not signiﬁcantly different
for either cell percentages or absolute cell numbers (see
Figure 6A and B). In addition, the cytokine mRNA expression
measured in 4-week-old SAMP livers showed increased
interleukin 1b (IL-1b), interferon-g (IFNg), and tumor ne-
crosis factor, and decreased IL-4, IL-13, and IL-10 compared
with age-matched AKR mice (see Figure 6C), demonstratingthat the cytokine milieu during peak hepatic inﬂammation is
skewed toward a proinﬂammatory/TH1 proﬁle.
Based on these data, we evaluated the requirement of
lymphocytes for the development of SAMP hepatic inﬂam-
mation. As such, we generated SAMPXRag-1/ mice by
backcrossing Rag-1-deﬁcient mice24 onto the SAMP back-
ground to produce SAMP lacking mature T and B lympho-
cytes. We found that SAMPXRag-1/ mice developed only
mild, if any, liver inﬂammation compared with SAMPXRag-
1þ/þ littermates (Figure 7A). Similarly, SAMPXRag-1/
mice also displayed attenuated ileitis compared with
SAMPXRag-1þ/þ littermates at 10 and 20 weeks (see
Figure 7B) when ileal inﬂammation is normally established
in native SAMP mice, whereas similar levels of inﬂammation
were observed at 4 weeks of age.
Given the abundance of T lymphocytes in SAMP livers
and their suggested role in IBD-associated liver diseases,25
we measured the frequency of CD4þ and CD8þ subsets in
4-week-old SAMP and AKR livers. Interestingly, CD4þ but
not CD8þ T cells were increased in SAMP livers and dis-
played a greater expression of the activation markers CD69
and CD44 compared with CD4þ T-cells from AKR livers (see
Figure 7C). The activated phenotype of SAMP intrahepatic
CD4þ T cells was consistent with the increased production
of proinﬂammatory/TH1 cytokines by NPLC (see Figure 6C).
These data suggest the presence of an increased pool of
activated intrahepatic CD4þ Teff population in SAMP liver,
which may play a role in the liver inﬂammation.
SAMP-Derived Hepatic CD4þ T Cells Can
Transfer Both Liver Inﬂammation and Ileitis Into
Immunodeﬁcient Recipient Mice Whereas
Gut-Associated Lymphoid Tissue-Derived CD4þ
T Cells Transfer Only Ileitis
Given the ability of gut-associated lymphoid tissue
(GALT)-derived CD4þ T cells from SAMP mice to induce
ileitis when adoptively transferred into immunodeﬁcient re-
cipients,11,17,19,26 we tested the in vivo pathogenic potential
of SAMP intrahepatic CD4þ T cells. The CD4þ T cells were
isolated from MLNs and livers of 10- to 12-week-old SAMP
and AKR mice (an age when both liver and ileal inﬂammation
Figure 5. Flow cytometric strategy for analysis of hematopoietic cells in SAMP1/YitFc (SAMP) and AKR/J (AKR) livers.
Nonparenchymal liver cells (NPLC) were isolated from (A) AKR and (B) SAMP livers by enzymatic digestion and used for
ﬂow cytometric analysis without any additional enrichment. Figure shows sequential gating on nondebris cells by FSC-A and
SSC-A, followed by exclusion of nonhematopoietic cells by CD45 positive expression. CD45þ hematopoietic cells were then
investigated for additional markers. Representative plots for CD3 and CD4 expression in (A) AKR and (B) SAMP livers are
shown.
Figure 4. Histologic features of SAMP1/YitFc (SAMP) hepatic inﬂammation closely resemble liver disease observed in
inﬂammatory bowel disease (IBD) patients. Main, pathologic features of SAMP liver include (A) inﬁltration of the portal-
parenchymal interface with (B) occasional inﬂammatory bridging (arrows) between portal tracts, (C) ductular proliferation,
and (D) hepatocyte anisokaryosis with inﬂammatory inﬁltration of liver lobules, often in the form of (E) granulomas. In a limited
number of SAMP, (F) mild microvesicular steatosis occurs in association with sinusoidal inﬂammation. Importantly, (G) focal
CD3þ T-cell inﬁltration (arrows) was observed in the bile duct epithelium. BD, bile duct; PV, portal vein. Bars: (A–C, E) 50 mm,
(F, G) 20 mm, and (D) 100 mm.
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Figure 6. SAMP1/YitFc
(SAMP) liver is abun-
dantly inﬁltrated with T
lymphocytes that display
a TH1-skewed cytokine
proﬁle. (A) Percentages
and (B) absolute numbers
(Abs #) of intrahepatic
positive cells for F4/80,
CD11c, CD19, and CD3 in
total cell gate from young
SAMP and AKR/J (AKR);
one observation (n) repre-
sents pooled samples
from two mice (n ¼ 4). (C)
Relative mRNA expression
of hepatic TH1, TH2, and
proinﬂammatory cytokines
in nonparenchymal liver
cells (NPLC) from 4-week-
old mice (n ¼ 8). *P < .05,
**P < .01, ***P < .001
versus AKR. n.s., not sta-
tistically signiﬁcant.
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Our results showed that naïve SCIDs receiving CD4þ T cells
from SAMP livers progressively lost more body weight
compared with those receiving cells from SAMP MLNsA 
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AKR donor T cells (see Figure 8B).
Importantly, the prominent ileitis that developed in
recipient mice after transfer of liver-derived SAMP CD4þ Tcells was more severe than the ileitis observed after
transfer of MLN-derived cells as well as in the control
(untransferred) recipients, which displayed no histologic
signs of inﬂammation (see Figure 8B and C). Similar to
414 Omenetti et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 4native SAMP (see Figure 6C), intrahepatic CD4þ T cells
from SCIDs receiving SAMP liver cells expressed higher
mRNA transcript levels of tumor necrosis factor and IFNg
compared with those receiving MLN T cells (see
Figure 8D).
We next asked whether the activated phenotype of
SAMP hepatic CD4þ T cells results in greater proliferation
of CD4þ Teff cells, which may explain the increased
severity of ileitis induced in SCID recipients receiving
liver-derived compared with MLN-derived CD4þ T cells.
Interestingly, the percentage of dividing cells was signiﬁ-
cantly increased (reduced 5-(6)-carboxyﬂuorescein diac-
etate succinimidyl ester) in 10-week-old SAMP livers
compared with AKR livers. Although both SAMP liver- and
MLN-derived Teff displayed increased percentages of
proliferating cells compared with AKR controls, the liver-
derived Teff showed greater proliferation than MLN-
derived Teff from SAMP mice (see Figure 8E–G). A
greater proliferation of Teff was observed in both SAMP
and AKR liver-versus MLN-derived cells, suggesting
increased activation of the liver compared to GALT,
although only SAMP intrahepatic CD4þ T cells are able to
induce liver inﬂammation in SCID recipients. Together,
these data suggest that the heightened activation status of
SAMP hepatic Teff cells may partially account for the
increased pathogenic potential of these cells compared to
GALT- and liver-derived AKR Teff cells.Accumulation of a4b7
þ CCR9þ CD4þ T Cells Is
Not Present in Inﬂamed SAMP Versus AKR Livers
According to the most commonly accepted hypothesis,
IBD-associated liver inﬂammation is the result of lympho-
cyte homing, speciﬁcally of either a4b7
þ and/or CCR9þ cells
that are originally activated in the gut and subsequently
recruited to the liver.2 Therefore, we asked whether
accumulation of either a4b7
þ and/or CCR9þ CD4þ T lym-
phocytes could be observed during established hepatic
inﬂammation in SAMP, similarly to what is observed for
CD8þ T lymphocytes in PSC patients.4,5 Interestingly, no
differences in the percentages of CD4þ T cells positive or
highly expressing a4b7 and/or CCR9 were observed in
SAMP versus AKR livers (Figure 9A). However, when ab-
solute numbers of a4b7
þ and CCR9þ CD4þ T cells were
measured, we observed an increase in a4b7
þ, a4b7
high, andFigure 8. (See previous page). SAMP1/YitFc (SAMP) intrahe
mation and ileitis. (A) Change in body weight (DBW), and (B
transfer of donor CD4þ T cells; recipients receiving vehicle only
photomicrographs displaying epithelial crypt hypertrophy and
ﬁltrates throughout mucosa and submucosa in recipients of li
adoptively transferred with mesenteric lymph node (MLN)-deriv
mRNA expression in activated ex vivo cultured intrahepatic CD
cells. (E) Percentages of Teff proliferation in liver and MLN o
represent dividing cells in the presence of aCD3/CD28. Results
experiment). (F, G) Representative histograms show proliferatio
the absence (gray peaks) and presence (white peaks) of aCD3/C
aCD3/CD28. Bars: 50mm; *P < .05, **P < .01, ***P < .005 versu
cells or AKR controls. n.s., not statistically signiﬁcant.CCR9þ CD4þ T cells (see Figure 9B), which likely reﬂects
the increased cellularity of SAMP versus AKR livers (see
Figure 9C).
To clarify whether increased expression of a4b7 and
CCR9 within intrahepatic CD4þ T cells results from the
recruitment of gut-activated a4b7
þ and CCR9þ CD4þ T
lymphocytes or, alternatively, from local imprinting of these
molecules,27 we evaluated protein expression of MAdCAM-1
and CCL25, the cognate ligands for a4b7 and CCR9, respec-
tively, for which aberrant hepatic expression is thought to
facilitate recruitment of gut-activated T-lymphocytes to the
liver in PSC.4,5 MAdCAM-1 and CCL25 protein expression,
however, was unchanged in SAMP compared with AKR
livers (see Figure 9D), suggesting that the expression of
a4b7
þ and CCR9þ is likely imprinted to CD4þ T cells in the
SAMP liver. In fact, differently from other hepatic APCs,
LSEC have been reported to promote gut tropism by
inducing expression of a4b7 and CCR9 on CD4þ T cells
within the liver.27 Although LSEC frequency is decreased in
the SAMP versus AKR liver (Figure 10A), these cells display
an increase in MHC class II expression compared to those
found in AKR livers (see Figure 10B), suggesting increased
antigen presentation to CD4þ T cells in SAMP versus AKR
livers. Together, these data suggest that enhanced recruit-
ment of gut-activated CD4þ T cells to the liver is not likely
the main initiating factor driving liver inﬂammation in SAMP
mice.SAMP Liver-Derived Regulatory T Cells Are
Impaired in Their In Vitro Immunosuppressive
Capability
Because it is unlikely that the bulk of activated intra-
hepatic CD4þ T cells are recruited from the gut to initiate
SAMP liver inﬂammation, we asked whether locally
impaired immunosuppression may occur within the liver of
these mice. First, we measured the frequency of FoxP3þ
Tregs within the CD4þ gate by ﬂow cytometry in SAMP
and AKR livers. Although the percentages of Tregs were
decreased within the overall CD4þ population (Figure 11A
and B), there was no signiﬁcant difference in the absolute
numbers of Tregs in SAMP compared with AKR livers (see
Figure 11C), which again, is likely due to the increased
cellularity observed in SAMP livers (see Figure 9C). These
data suggest that Tregs are likely outnumbered within thepatic TH1 effector T cells (Teff) transfer both liver inﬂam-
) liver and ileal inﬂammation in recipient mice after adoptive
served as controls (Ctrl) (n ¼ 8). (C) Representative histologic
elongation, and villous blunting with dense inﬂammatory in-
ver-derived donor cells (top), which were less severe in ilea
ed donor cells (middle) and Ctrl (lower). (D) TH1/TH2 cytokine
4þ T cells from recipients of donor SAMP liver versus MLN
f 10-week-old SAMP and AKR/J (AKR) mice. Percentages
are from four independent experiments (ﬁve mice pooled per
n of (F) liver- and (G) MLN-derived viable, CD4-gated cells in
D28. Percentages represent dividing cells in the presence of
s SCID receiving AKR donor cells, SAMP MLN-derived donor
Figure 10. Liver sinusoidal endothelial cells (LSEC) are
Figure 9. In SAMP1/YitFc (SAMP)
livers, a4b7
D and CCR9D CD4D
T cells do not accumulate. (A)
Percentages and (B) absolute
numbers (Abs #) of intrahepatic
CD4þ T-cell subsets from 4-week-
old SAMP and AKR/J (AKR). Iso-
lated nonparenchymal liver cells
(NPLC) were ﬁrst gated on CD4
and successively on a4b7 and
CCR9, distinguishing between
overall positive cells and highly
expressing cells; one observation
(n) represents pooled samples
from two mice (n ¼ 5). (C) Total
NPLC numbers (#) isolated by
enzymatic digestion without any
additional enrichment from 10-
week-old SAMP and AKR livers
(n ¼ 8). (D) Protein concentrations
of hepatic mucosal addressin cell
adhesion molecule-1 (MAdCAM-1)
and CC chemokine ligand 25
(CCL25) (n ¼ 6). n.s. ¼ not statis-
tically signiﬁcant.
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decreased in absolute number in SAMP versus AKR livers.
In addition, to test whether the immunosuppressive
function of liver-resident Tregs is altered in SAMP, we
evaluated the capacity of Tregs to suppress in vitro prolif-
eration of Teff cells. Teff (CD4þCD25) and Treg
(CD4þCD25þ) cells were isolated from SAMP and AKR livers
by FACS, accordingly to the strategy depicted in Figure 12.
Suppression by Tregs is expressed as the percentage of
proliferating cells (eFluor 670 “low”) inhibited after cocul-
ture with Tregs, and was calculated by normalizing the
difference of proliferating cells with Tregs to the prolifera-
tion in the absence of Tregs. Interestingly, liver-resident
Tregs from SAMP were less effective at suppressing the
proliferation of hepatic Teff cells compared with Tregs from
AKR (see Figure 11D and E).
These data demonstrate that liver-resident Tregs from
SAMP are dysfunctional in vitro and unable to suppress the
proliferation of hepatic Teff cells as effectively as Tregs from
AKR control mice. Overall, these ﬁndings suggest that
impaired suppressive function of hepatic Tregs in SAMP
liver is permission for the unrestrained proliferation of
pathogenic TH1-activated CD4
þ T cells, resulting in a biased,
increased Teff/Treg ratio that leads to liver inﬂammation in
these mice.decreased in SAMP1/YitFc (SAMP) livers but display
greater expression of MHC class II compared with AKR/J
(AKR) livers. (A) Percentages of intrahepatic positive cells for
CD146þ (LSEC) in total cell gate, and for (B) IAk in CD146þ
gate in inﬂamed young SAMP and AKR controls. One
observation (n) represents pooled samples from two mice
(n ¼ 5).Discussion
Although liver disease has previously been reported in
ileitis-prone SAMP mice,13,14 the precise histologic features,
onset and progression of disease, pathogenic mechanism(s),and it’s the translational implications to IBD have not
been fully addressed. Interestingly, evaluation of SAMP
livers suggests a clinical phenotype resembling PSC/AIH
overlap syndrome, which can also represent a comorbidity
with IBD1. PSC/AIH overlap syndrome is deﬁned as an
immune-mediated disorder with cholangiographic ﬁndings,
and histologic, biologic and/or clinical features of AIH.
Histologic characteristics of AIH include piecemeal necrosis,
lymphocyte rosetting, and moderate to severe periportal or
periseptal inﬂammation,28 which are features also found in
SAMP livers (see Figure 1B and D, and Figure 4). Nonethe-
less, although SAMP mice exhibit many histologic
Figure 11. In vitro sup-
pressive function of reg-
ulatory T cells (Tregs)
but not their absolute
number is altered in
SAMP1/YitFc (SAMP)
versus AKR/J (AKR)
livers. (A) Percentages of
intrahepatic FoxP3þ cells
calculated within CD4þ
gate, with (B) representa-
tive plots (n ¼ 3) in young
SAMP and AKR. (C) Abso-
lutes number (Abs #) of
intrahepatic FoxP3þ cells
isolated per mouse were
calculated within CD4þ
gate. (D) In vitro Treg sup-
pression activity in livers of
young SAMP and AKR
mice. Percent suppression
is expressed as the per-
centage of effector T cell
(Teff) proliferation that was
suppressed by coculture
with Tregs. Results are
from four independent ex-
periments (15 mice pooled
per experiment). (E) Rep-
resentative histograms
showing proliferation of
viable, CD4-gated cells in
the absence (gray peaks)
and presence (white peaks)
of hepatic Tregs. Percent-
ages represent dividing
cells in the presence of
Tregs. *P < .05, **P < .001.
n.s., not statistically
signiﬁcant.
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does not fully represent classic PSC but rather a comorbidity
model of IBD and inﬂammatory liver disease. In fact,
PSC-associated IBD also displays different clinical manifes-
tations with respect to IBD alone, suggesting that PSC-
associated IBD may constitute a unique IBD phenotype in
itself.29
As such, SAMP mice may serve as an informative and
useful model for PSC, but also other types of inﬂammatory
liver diseases that coexist with IBD. Importantly, although
liver involvement in IBD is commonly regarded as a
consequential secondary event to gut inﬂammation, we
report peak hepatic inﬂammation in SAMP at 4 weeks of
age, before the onset of ileitis (see Figure 2A). This ﬁnding
suggests that in SAMP the presence of an inﬂamed gut is not
required to trigger hepatic inﬂammation and that other
mechanism(s) intrinsic to the liver or host may induce liver
disease.
The absence of hepatic inﬂammation observed in
SAMPXRag-1/ mice (see Figure 7A), wherein the lack ofmature lymphocytes is sufﬁcient to abrogate liver disease,
demonstrates that functional lymphocytes are required for
the development of SAMP liver disease. Moreover, in the
absence of mature lymphocytes, the amelioration of disease
was more pronounced in the liver than in the ileum when
comparing the relative reduction in inﬂammatory scores
from SAMPXRag-1/ versus SAMPXRag-1þ/þ control mice
(see Figure 7A and B). As such, although lymphocytes
appear to play a pivotal role in SAMP ileitis,12 the contri-
bution of the nonhematopoietic compartment16 appears to
be particularly crucial for ileal, compared to liver, inﬂam-
mation to develop.
Furthermore, the abundant accumulation of T but not
B lymphocytes in the inﬂammatory inﬁltrates of SAMP
liver (see Figure 6A and B) suggests that these cells may
play a role in inducing and/or sustaining the hepatic
inﬂammation in SAMP mice. Similar to the early inductive
phase of ileitis wherein TH1 cytokines predominate,
11 the
SAMP hepatic environment is also TH1-biased (see
Figure 6C) and enriched for activated CD4þ T cells (see
Figure 13. MHC class II expression is not increased in
SAMP1/YitFc (SAMP) versus AKR/J (AKR) hepatic den-
dritic cells (DC) and Kupffer cells (KC). Percentages of
intrahepatic positive cells for IAk within (A) F4/80þ gate (KC)
and (B) CD11cþ gate (DC) in inﬂamed young SAMP and AKR
controls. One observation (n) represents pooled samples
from two mice (n ¼ 5).
Figure 12. FACS sorting strategy for isolation of CD4DCD25L and CD4DCD25D cells. CD4þCD25 and CD4þCD25þ cells
were isolated from SAMP1/YitFc (SAMP) and AKR/J (AKR) mice, using Percoll gradients for livers and CD4 magnetic beads for
mesenteric lymph node cells (MLNs), followed by FACS. Figure shows sequential gating on lymphocytes by FSC-A and SSC-
A, followed by exclusion of aggregates by SSC-W and SSC-A. Singlet lymphocytes were selected on CD4 positive ﬂuores-
cence and then on CD25 positive regulatory T (Treg) or negative effector T (Teff) expression.
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weeks, before ileitis, which suggests the presence of a
shared CD4þ T-cell-mediated pathogenic mechanism
between the two organs that is able to induce similar
phenotypes and immune responses, albeit temporally
separated. Moreover, SAMP-derived intrahepatic CD4þ
T cells are able to adoptively transfer both liver and
ileal inﬂammation, whereas GALT-derived CD4þ T cells
induce milder ileitis with respect to liver-derived cells but
are not sufﬁcient to transfer liver inﬂammation (see
Figure 8B).
Interestingly, the increased activation status of Teff
observed in SAMP liver (see Figure 8E) could partially ac-
count for the increased pathogenic potential of these cells
and their ability to induce liver inﬂammation in SCID re-
cipients. Although the greater proliferation observed in AKR
liver- versus MLN-derived Teff cells suggests an increased
baseline activation of the liver compared with GALT, only
SAMP intrahepatic CD4þ T cells are able to induce liver
inﬂammation in SCID recipients. Therefore, the unique
pathogenic potential of SAMP intrahepatic CD4þ T cells
appears to be both organ- and host-restricted. These results
suggest that the liver, rather than the gut, may provide a
pool of pathogenic TH1 CD4
þ T cells able to induce hepatic
inﬂammation, contrary to the widely accepted hypothesis
that IBD-associated liver inﬂammation is mediated by long-
lived, GALT-derived a4b7þ and CCR9þ T-lymphocytes later
recruited to the liver.5,25,30 In addition, although the abso-
lute numbers of intrahepatic a4b7þ and CCR9þ CD4þ T cells
were increased in SAMP versus AKR livers (see Figure 9B),
we were unable to detect any signiﬁcant differences in
either the percentages of intrahepatic a4b7þ and CCR9þ
CD4þ T cells or their corresponding ligands MAdCAM-1 and
CCL25 during peak hepatic inﬂammation in SAMP versus
AKR (see Figure 9A and D), which is different from what has
been observed for the ileal phenotype.14,20,21,31 This
provides further evidence supporting the hypothesis that
host hepatic defects rather than aberrant recruitment of gut-
activated lymphocytes may be responsible for the ileitis-
associated liver phenotype observed in SAMP mice.
Effector functions of intrahepatic T-lymphocytes depend
both on their site of primary activation and on the type ofT cells considered, particularly whether these are CD4þ or
CD8þ T lymphocytes.6,32 Increasing evidence suggests that
antigen presentation in the liver mainly results in activation
of CD8þ T cells whereas the effect on CD4þ lymphocytes is
still controversial.7,8,33 Despite the proinﬂammatory envi-
ronment characteristic of the SAMP liver during peak
inﬂammation, we could not detect signiﬁcant differences in
intrahepatic DC and macrophage (KC) frequencies (see
Figure 6A and B) and their MHC class II expression
(Figure 13A and B) when comparing the SAMP and AKR
livers. Therefore, increased antigen presentation by tradi-
tional liver-resident APCs are unlikely to represent the main
mechanism by which CD4þ T cells acquire pathogenic po-
tential in the inﬂamed SAMP liver.
The hypothesis that unrestrained proliferation of Teff cells
contributes to IBD-associated liver disease has already been
suggested by the ability of CD4þCD45RBhigh cells to induce
liver inﬂammation together with colon and small bowel
inﬂammation when transferred into lymphopenic mice.34
Nevertheless, the role of Teff cells versus regulatory com-
partments has not been thoroughly investigated in IBD-
associated liver disease. We report a diminished percentage
of SAMP hepatic FoxP3þ Tregs in the overall CD4þ compart-
ment; however, the absolute numbers are unchanged with
respect to AKR livers (see Figure 11A–C), suggesting that the
homeostatic Teff/Treg ratio is altered in the inﬂamed SAMP
418 Omenetti et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 4liver. Moreover, in vitro evaluation of the Treg suppressive
capacity indicates that SAMP hepatic Tregs are dysfunctional,
similar to what has been observed for SAMP ileitis.35
Mechanistically, the disruption of hepatic tolerance in
favor of uncontrolled proliferation of pathogenic TH1 CD4
þ T
cells may also be facilitated by altered LSEC frequency and
function. Indeed, LSEC can induce both FoxP3 positive and
negative Tregs, but they can also suppress CD4 and CD8
effector T cells8,36–38 and are considered to be critical for
promoting hepatic T-cell tolerance. Typically, antigen pre-
sentation by LSEC to CD4þ T cells does not result in an
effective immune response but rather leads to the induction
of hepatic tolerance.8,33 LSEC normally express low levels of
MHC class II as a consequence of exposure to IL-10, abundant
in the homeostatic liver, which determines a shift from an
activated to inhibitory phenotype with the ability to suppress
IFNg secretion from CD4þ T cells.36,39 CD146þ LSEC are not
only decreased in frequency in inﬂamed SAMP livers but also
display a greater expression of MHC class II (see Figure 10),
consistent with increased expression of a4b7 and CCR9
among intrahepatic CD4þ T cells (see Figure 9A), as well as
diminished IL-10 in SAMP NPLC (see Figure 6C). As such,
down-regulation of IL-10 in inﬂamed SAMP livers could
determine a shift in LSEC phenotype and function, impairing
their ability to effectively suppress TH1 CD4
þ T cells.
Overall, these results support a pathogenic role for
inherent intrahepatic CD4þ T cells in SAMP liver and intestinal
inﬂammation, and suggest that impaired hepatic immune
tolerance may be responsible for their acquired pathogenicity
and function. These ﬁndings also raise the possibility that
IBD-associated liver disease does not simply represent an
extraintestinal manifestation of a primary inﬂammatory gut
phenotype, but that liver and intestinal inﬂammation in IBD
patients may develop as concomitant disease processes
based on common host-driven immune defects.
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